Prognostic value and cost‐effectiveness of different screening strategies for HLA antibodies prior to kidney transplantation

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Transplantation

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1399-0012.2012.01615.xPMID 22432638
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of Induction Therapy with ATG and Intravenous Immunoglobulins in Patients with Low‐Level Donor‐Specific HLA‐Antibodies

  2010cited by this paper
• The 'blood group O problem' in kidney transplantation--time to change?

  2010cited by this paper
• Costs of dialysis--a regional population-based analysis.

  2010influential reference
• Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.

  2010cited by this paper
• Donor-Specific Antibody Levels and Three Generations of Crossmatches to Predict Antibody-Mediated Rejection in Kidney Transplantation

  2010cited by this paper
• Clinical relevance of circulating donor-specific HLA antibodies

  2010cited by this paper
• C4d-Fixing Capability of Low-Level Donor-Specific HLA Antibodies Is Not Predictive for Early Antibody-Mediated Rejection

  2010cited by this paper
• Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation.

  2010cited by this paper
• Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.

  2009influential reference
• Clinical Relevance of Pretransplant Donor-Specific HLA Antibodies Detected by Single-Antigen Flow-Beads

  2009cited by this paper
• Clinical relevance of preformed C4d‐fixing and non‐C4d‐fixing HLA single antigen reactivity in renal allograft recipients

  2009cited by this paper
• Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.

  2009cited by this paper
• Pretransplant Donor-Specific Antibodies in Cytotoxic Negative Crossmatch Kidney Transplants: Are They Relevant?

  2008cited by this paper
• “Natural” Human Leukocyte Antigen Antibodies Found in Nonalloimmunized Healthy Males

  2008influential reference
• Clinical Relevance of Preformed HLA Donor‐Specific Antibodies in Kidney Transplantation

  2008influential reference
• Review of nonimmunological causes for deteriorated graft function and graft loss after transplantation

  2008influential reference
• Clinical Relevance of Pretransplant Donor-Directed Antibodies Detected by Single Antigen Beads in Highly Sensitized Renal Transplant Patients

  2008influential reference
• Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.

  2008cited by this paper
• Luminex technology for anti‐HLA antibody screening: Evaluation of performance and of impact on laboratory routine

  2007cited by this paper
• Accommodation of grafts: implications for health and disease.

  2007cited by this paper
• In Vitro Detection of C4d‐Fixing HLA Alloantibodies: Associations With Capillary C4d Deposition in Kidney Allografts

  2007influential reference
• Renal Transplantation in Patients With Pre‐Transplant Donor‐Specific Antibodies and Negative Flow Cytometry Crossmatches

  2007influential reference
• Identification of dialysis patients with panel-reactive memory T cells before kidney transplantation using an allogeneic cell bank.

  2006cited by this paper
• A structurally based approach to determine HLA compatibility at the humoral immune level.

  2006cited by this paper
• The Banff 97 working classification of renal allograft pathology.

  1999cited by this paper
• Significance of the positive crossmatch test in kidney transplantation.

  1969cited by this paper

• Determination of unacceptable HLA antigen mismatches in kidney transplant recipients

  2021cites this paper
• Predictive value of mixed antigen screen beads in pre‐transplant assessment of HLA immunization in solid organ transplant recipients

  2020cites this paper
• Impact of Adopting Routine Luminex-Based Pretransplant Assessment of HLA Antibodies on Clinical Practice and Outcomes in Kidney Transplantation.

  2019cites this paper
• Discrepant Antibody Testing Results: Which One to Believe?

  2019cites this paper
• Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs.

  2017cites this paper
• Single center experience of subclinical rejections and BK nephropathies by kidney allografts' surveillance biopsies.

  2017cites this paper
• Transplant immuno-diagnostics: crossmatch and antigen detection

  2016cites this paper
• How can we reduce costs of solid‐phase multiplex‐bead assays used to determine anti‐HLA antibodies?

  2016cites this paper
• The use of novel diagnostics to individualize immunosuppression following transplantation

  2015cites this paper
• Solid‐phase assays for the detection of alloantibody against human leukocyte antigens: Panacea or Pandora?

  2014cites this paper
• Evolving experience of treating antibody-mediated rejection following lung transplantation.

  2014cites this paper
• The Evolution of HLA-Matching in Kidney Transplantation

  2013cites this paper
• Detection of Antibody-Mediated Rejection in Kidney Transplantation and the Management of Highly Sensitised Kidney Transplant Recipients

  2013cites this paper
• Flow Cytometry in the Diagnosis of Myelodysplastic Syndromes

  2013influential citation
• Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies

  2013cites this paper
• Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?

  2013cites this paper
• Measurement of Soluble Biomarkers by Flow Cytometry

  2013cites this paper